A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home AIMD Business Boston Scientific Announces Q4 2013 Results: CRM Up 3%
formats

Boston Scientific Announces Q4 2013 Results: CRM Up 3%

Boston Scientific Logo

Boston Scientific announced that it has continued to improve performance in the company’s Cardiac Rhythm Management business, achieving revenue growth of 3 percent versus the prior year period on a constant currency basis from $457M to $468M.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Announces Q4 2013 Results: CRM Up 3%  comments